|
|
|
|
| LEADER |
01679nam a2200325 u 4500 |
| 001 |
EB001872152 |
| 003 |
EBX01000000000000001035523 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
190824 r ||| eng |
| 100 |
1 |
|
|a Chao, Yi-Sheng
|
| 245 |
0 |
0 |
|a Ulipristal versus levonorgestrel for emergency contraception
|h Elektronische Ressource
|b a review of comparative clinical effectiveness and guidelines
|c Yi-Sheng Chao, Nina Frey
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c November 29, 2018, 2018
|
| 300 |
|
|
|a 1 PDF file (20 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Contraception, Postcoital
|
| 653 |
|
|
|a Norpregnadienes
|
| 653 |
|
|
|a Norgestrel
|
| 653 |
|
|
|a Contraceptives, Postcoital / therapeutic use
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Guidelines as Topic
|
| 700 |
1 |
|
|a Frey, Nina
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK538737
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a In 2014, Health Canada issued a warning that levonorgestrel might not be as effective for individuals weighing more than 165 pounds. The role of the factors modifying the effectiveness of emergency contraception are important. This review aims to compare the effectiveness of levonorgestrel and ulipristal for emergency contraception based on the latest evidence
|